RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Washington D.C., DC · +50 more sites
3 recruiting rheumatoid arthritis studies with a site in Washington D.C., DC.
All trials in Washington D.C., DC · All Rheumatoid Arthritis trials
Sponsor: National Cancer Institute (NCI)
Washington D.C., DC · +50 more sites
Sponsor: Duke University
Washington D.C., DC · +74 more sites
Sponsor: Children's Hospital of Philadelphia
Washington D.C., DC · +22 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.